Amarin Market Capitalization from 2010 to 2025

AMRN Stock  USD 0.55  0.02  3.77%   
Amarin PLC Market Cap yearly trend continues to be very stable with very little volatility. Market Cap is likely to grow to about 1.8 B this year.
Check Amarin PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amarin PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 6.8 K or Selling General Administrative of 68.4 M, as well as many indicators such as Price To Sales Ratio of 0.99, Dividend Yield of 0.0 or PTB Ratio of 0.78. Amarin financial statements analysis is a perfect complement when working with Amarin PLC Valuation or Volatility modules.
  
Check out the analysis of Amarin PLC Correlation against competitors.
To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.

Latest Amarin PLC's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Amarin PLC over the last few years. It is Amarin PLC's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amarin PLC's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 227.59 M10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Amarin Market Capitalization Regression Statistics

Arithmetic Mean1,180,932,029
Geometric Mean795,072,828
Coefficient Of Variation65.64
Mean Deviation735,433,886
Median1,764,127,427
Standard Deviation775,207,245
Sample Variance600946.3T
Range1.8B
R-Value0.87
Mean Square Error161222.1T
R-Squared0.75
Significance0.000015
Slope140,974,393
Total Sum of Squares9014194.1T

Amarin Market Capitalization History

20251.8 B
20241.7 B
20171.9 B
2016648.7 M
2011339.4 M
201037.3 M

About Amarin PLC Financial Statements

Amarin PLC investors utilize fundamental indicators, such as Market Capitalization, to predict how Amarin Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Amarin Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 560 people.

Pair Trading with Amarin PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amarin PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarin PLC will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amarin Stock

  0.73DNLI Denali TherapeuticsPairCorr
  0.69EVOK Evoke PharmaPairCorr
  0.71FOLD Amicus TherapeuticsPairCorr
  0.79JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr

Moving against Amarin Stock

  0.77LFCR Lifecore BiomedicalPairCorr
  0.64BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.55GILD Gilead SciencesPairCorr
  0.41IMCC Im Cannabis CorpPairCorr
The ability to find closely correlated positions to Amarin PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amarin PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amarin PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amarin PLC to buy it.
The correlation of Amarin PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amarin PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amarin PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amarin PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amarin PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amarin PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amarin Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amarin Plc Stock:
Check out the analysis of Amarin PLC Correlation against competitors.
To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.94)
Earnings Share
(0.10)
Revenue Per Share
0.588
Quarterly Revenue Growth
(0.36)
Return On Assets
(0.03)
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.